Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
solute carrier family 6 member 4 gene promoter | 0.626 | 0.423 |
|
disease | 0.090 | None | 1.000 | 9 | 0 | 1999 | 2019 | |||||||||
|
centralopathic epilepsy | 0.626 | 0.423 |
|
disease | 0.080 | None | 1.000 | 8 | 0 | 1985 | 2019 | |||||||||
|
Major depressive disorder | 0.682 | 0.308 |
|
disease | 0.070 | None | 1.000 | 7 | 0 | 2008 | 2019 | |||||||||
|
cat eye syndrome chromosome region | 0.599 | 0.731 |
|
disease | 0.060 | None | 1.000 | 6 | 0 | 2017 | 2018 | |||||||||
|
LINC02210-CRHR1 readthrough | 0.570 | 0.692 |
|
disease | 0.150 | None | 1.000 | 5 | 10 | 2006 | 2018 | |||||||||
|
microRNA 132 | 0.485 | 0.846 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 2015 | 2018 | |||||||||
|
dendritic cell associated nuclear protein | 0.839 | 0.154 |
|
disease | 0.330 | None | 0.667 | 3 | 2 | 2010 | 2013 | |||||||||
|
interferon alpha 1 | 0.371 | 0.923 |
|
disease | 0.330 | None | 1.000 | 3 | 0 | 2012 | 2019 | |||||||||
|
interferon alpha 13 | 0.374 | 0.923 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2012 | 2019 | |||||||||
|
microRNA 221 | 0.449 | 0.846 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2018 | 2019 | |||||||||
|
T cell receptor delta locus | 0.650 | 0.692 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2017 | 2019 | |||||||||
|
microRNA 1202 | 0.729 | 0.385 |
|
disease | 0.320 | None | 1.000 | 2 | 0 | 2014 | 2017 | |||||||||
|
TSNAX-DISC1 readthrough (NMD candidate) | 0.729 | 0.154 |
|
disease | 0.320 | None | 1.000 | 2 | 4 | 2010 | 2012 | |||||||||
|
P2RX5-TAX1BP3 readthrough (NMD candidate) | 0.588 | 0.769 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2009 | 2013 | |||||||||
|
MT-CO2 pseudogene 12 | 0.368 | 0.962 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2018 | 2019 | |||||||||
|
cytochrome P450 2D6 | 0.597 | 0.769 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2013 | 2016 | |||||||||
|
microRNA 155 | 0.384 | 0.885 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2018 | 2019 | |||||||||
|
microRNA 212 | 0.535 | 0.808 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2016 | 2018 | |||||||||
|
microRNA 34b | 0.509 | 0.808 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2016 | 2017 | |||||||||
|
sperm mitochondria associated cysteine rich protein | 0.621 | 0.692 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2017 | 2019 | |||||||||
|
cytochrome c oxidase subunit II | 0.352 | 0.962 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2018 | 2019 | |||||||||
|
BDNF antisense RNA | 0.638 | 0.538 |
|
disease | 0.020 | None | 1.000 | 2 | 10 | 2015 | 2019 | |||||||||
|
chromosome 20 open reading frame 181 | 0.479 | 0.885 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | |||||||||
|
psoriasis susceptibility 1 candidate 3 | 0.769 | 0.269 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | |||||||||
|
microRNA 664a | 0.644 | 0.538 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2016 | 2016 |